Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;21(1):44-62.
doi: 10.1038/s41576-019-0171-x. Epub 2019 Sep 23.

Context is everything: aneuploidy in cancer

Affiliations
Review

Context is everything: aneuploidy in cancer

Uri Ben-David et al. Nat Rev Genet. 2020 Jan.

Abstract

Cancer is driven by multiple types of genetic alterations, which range in size from point mutations to whole-chromosome gains and losses, known as aneuploidy. Chromosome instability, the process that gives rise to aneuploidy, can promote tumorigenesis by increasing genetic heterogeneity and promoting tumour evolution. However, much less is known about how aneuploidy itself contributes to tumour formation and progression. Unlike some pan-cancer oncogenes and tumour suppressor genes that drive transformation in virtually all cell types and cellular contexts, aneuploidy is not a universal promoter of tumorigenesis. Instead, recent studies suggest that aneuploidy is a context-dependent, cancer-type-specific oncogenic event that may have clinical relevance as a prognostic marker and as a potential therapeutic target.

PubMed Disclaimer

Comment in

  • Aneuploidy in the driving seat.
    Clyde D. Clyde D. Nat Rev Genet. 2021 Oct;22(10):624-625. doi: 10.1038/s41576-021-00411-2. Nat Rev Genet. 2021. PMID: 34376820 No abstract available.

References

    1. Boveri, T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J. Cell Sci. 121, 1–84 (2008). - DOI - PubMed - PMC
    1. Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13, 189–203 (2012). - PubMed - DOI - PMC
    1. van Jaarsveld, R. H. & Kops, G. Difference makers: chromosomal instability versus aneuploidy in cancer. Trends Cancer 2, 561–571 (2016). - PubMed - DOI - PMC
    1. Sheltzer, J. M. & Amon, A. The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet. 27, 446–453 (2011). - PubMed - PMC - DOI
    1. Sheltzer, J. M. et al. Single-chromosome gains commonly function as tumor suppressors. Cancer Cell 31, 240–255 (2017). This study shows that the experimental introduction of extra chromosomes into mammalian cells is tumour-suppressive. - PubMed - PMC - DOI

Publication types

LinkOut - more resources